Screening for thyroid disease: Defining high-risk populations

Expert Review of Endocrinology and Metabolism

Volumn 5, Issue 5, 2010, Pages 663-671

  Stein, Stephanie Aleskow ^a   Wartofsky, Leonard ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

hyperthyroidism; hypothyroidism; population screening; subclinical thyroid disease; thyroid cancer; thyroid disease

Indexed keywords

AMIODARONE; IODINE 131; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADDISON DISEASE; AUTOIMMUNE DISEASE; CASE FINDING; CIGARETTE SMOKING; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; IODINE DEFICIENCY; MASS SCREENING; PERNICIOUS ANEMIA; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST; THYROID CANCER; THYROID DISEASE; THYROID NODULE;

EID: 77956838484     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.10.34     Document Type: Review

References (58)

1. Cooper DS. Subclinical hypothyroidism. N. Engl. J. Med. 345(4), 260-265 (2001).
2. Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J. Clin. Endocrinol. Metab. 92(1), 203-207 (2007).
3. Ladenson PW, Singer PA, Ain KB et al. American thyroid association guidelines for detection of thyroid dysfunction. Arch. Intern. Med. 160(11), 1573-1575 (2000).
4. Surks MI, Oritz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291(2), 228-238 (2004).
5. Nayak B, Hodak SP. Hyperthyroidism. Endocrinol. Metab. Clin. North Am. 36 (3), 617-656 (2007).
6. Larsen PR, Davies TF, Schlumberger MJ, Hay ID. Chapter 10 - thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Kronenberg: Williams Textbook of Endocrinology (11th Edition). Saunders Elsevier, PA, USA 299-332 (2008).
7. McDermott MT, Ridgway EC. Clinical Perspective: subclinical hypothyroidism is mild thyroid failure and should be treated. J. Clin. Endocrinol. Metab. 86(10), 4585-4590 (2001).
8. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the united states population (1988 to 1994): national health and nutrition examination survey (NHANES III). J. Clin. Endocrinol. Metab. 87(2), 489-499 (2002).
9. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160(4), 526-534 (2000).
10. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann. Intern. Med. 132(4), 270-278 (2000).
11. Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. what is the evidence? Thyroid 17(11), 1075-1084 (2007).
12. Eisenbarth GS, Gottlieb PA. Medical progress: autoimmune polyendocrine syndromes. N. Engl. J. Med. 350(20), 2068-2079 (2004).
13. Umpierrez GE, Latif KA, Murphy MB et al. Thyroid dysfunction in patients with Type 1 diabetes. Diabetes Care 26(4), 1181-1185 (2003).
14. Owen JC, Cheetham TD. Diagnosis and management of polyendocrinopathy syndromes. Endocrinol. Metab. Clin. North Am. 38(2), 419-436 (2009).
15. Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimotos) thyroiditis in children and adolescents with vitiligo. J. Am. Acad. Dermatol. 53(2), 220-223 (2005).
16. Taeb A, Picardo M. Vitiligo. N. Engl. J. Med. 360(2), 160-169 (2009).
17. Bornstein SR. Current concepts: predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360(22), 2328-2339 (2009).
18. Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in addisons disease. J. Autoimmun. 8(1), 121-130 (1995).
19. Carmel R, Spencer CA. Clinical and subclinical thyroid disorders associated with pernicious anemia, observations on abnormal thyroid stimulating hormone levels and on a possible association of blood group O with hyperthyroidism. Arch. Intern. Med. 142(8), 1465-1469 (1982).
20. Ottesen M, Feldt-Rasmussen U, Andersen J, Hippe E, Schouboe A. Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. J. Endocrinol. Invest. 18(2), 91-97 (1995).
21. Azizi F. The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. Eur. J. Endocrinol. 153(3), 367-371 (2005).
22. Lucas A, Pizarro E, Granada ML, Salinas I, Roca J, Sanmarti A. Postpartum thyroiditis: long term followup. Thyroid 15(10), 1177-1181 (2005).
23. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 92(8), S1-S47 (2007).
24. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in danish twins. J. Clin. Endocrinol. Metab. 85(2), 536-539 (2000).
25. Ozawa H, Saitou H, Mizutari K, Takata Y, Ogawa K. Hypothyroidism after radiotherapy for patients with head and neck cancer. Am. J. Otolaryngol. 28(1), 46-49 (2006).
26. McHenry CR. Hypothyroidism following hemithyroidectomy: incidence, risk factors, and management. Surgery 128(6), 994-998 (2000).
27. Davies TF, Larsen PR. Chapter 11 - thyrotoxicosis. In: Kronenberg: Williams Textbook of Endocrinology (11th Edition). Saunders Elsevier, PA, USA 333-376 (2008).
28. Yen AW, Fancher TL, Bowlus CL. Revisiting hereditary hemochromatosis: current concepts and progress. Am. J. Med. 119(5), 391-399 (2006).
29. Benowitz NL, Brunetta PG. Chapter 90 - smoking hazards and cessation. In: Mason: Murray and Nadels Textbook of Respiratory Medicine (4th Edition). Saunders Elsevier, PA, USA (2005).
30. Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism: prevalence and clinical relevance. Neth. J. Med. 46(4), 197-204 (1995).
31. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331(19), 1249-1252 (1994).
32. Brix TH, Christensen K, Holm NV, Hegedus L. A population-based study of graves disease in danish twins. Clin. Endocrinol. 48(4), 397-400 (1998).
33. Brix TH, Kyvik KO, Hegedus L. What is the evidence of genetic factors in the etiology of graves disease? a brief review. Thyroid 8(11), 627-634 (1998). (Pubitemid 28354917)
34. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun. 30(1-2), 58-62 (2008).
35. Mallampalli A, Guntupalli K. Smoking and systemic disease. Clin. Occup. Environ. Med. 5(1), 173-192 (2006). (Pubitemid 43168913)
36. Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD. Smoking and other lifestyle factors and the risk of graves hyperthyroidism. Arch. Intern. Med. 165(14), 1606-1611 (2005).
37. Baskin JH, Cobin RH, Duick DS et al. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Pract. 8(6), 457-467 (2002).
38. Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet. Gynecol. 72(1), 108-112 (1988).
39. Montoro M, Collea JV, Frasier SD, Mestman JH. Successful outcome of pregnancy in women with hypothyroidism. Ann. Intern. Med. 94(1), 31-34 (1981).
40. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr. Rev. 18(3), 404-433 (1997).
41. Klein RZ, Haddow JE, Faix JD et al. Prevalence of thyroid deficiency in pregnant women. Clin. Endocrinol. (Oxf.) 35(1), 41-46 (1991).
42. Neale D, Burrow G. Thyroid disease and pregnancy. Obstet. Gynecol. Clin. North Am. 31(4), 893-905 (2004).
43. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am. J. Obstet. Gynecol. 160(1), 63-70 (1989).
44. LeBeau SO, Mandel SJ. Thyroid disorders during pregnancy. Endocrinol. Metab. Clin. North Am. 35, 117-136 (2006).
45. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet. Gynecol. 81(3), 349-353 (1993).
46. Casey B, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105(2), 239-245 (2005).
47. Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid 8(9), 859-864 (1998).
48. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet. Gynecol. 84(6), 946-949 (1994).
49. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet. Gynecol. 80(3), 359-364 (1992).
50. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin. Endocrinol. (Oxf.) 20(6), 695-700 (1984).
51. Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum:an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 92(8), S1-S47 (2007).
52. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States: 1973-2002. JAMA 295(18), 2164-2167 (2006).
53. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid cancer. Thyroid 19, 333-340 (2009).
54. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States. Cancer 115(16), 3801-3807 (2009).
55. Lal G, ODorisio T, McDougall R, Weigel RJ. Cancer of the endocrine system. In: Abeloff: Abeloff s Clinical Oncology (4th Edition) Churchill Livingstone, PA, USA (2008).
56. Alsanea O, Clark OH. Familial thyroid cancer. Curr. Opin Oncol. 13(1), 44-51 (2001).
57. Cobin RH, Gharib H, Bergman DA et al.; Thyroid Carcinoma Task Force. AACE/ AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr. Pract. 7(3), 202-220 (2001).
58. Cancer Facts and Figures 2009, American Cancer Society www.cancer.org/docroot/home/index.asp. (Accessed 25 March 2010)